4(5)-phenylimidazole has been researched along with Benign Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, HM; Tang, K; Wang, B; Yu, B | 1 |
1 review(s) available for 4(5)-phenylimidazole and Benign Neoplasms
| Article | Year |
|---|---|
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors and PROTAC-based degraders for cancer therapy.
Topics: Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Molecular Structure; Neoplasms; Proteolysis; Small Molecule Libraries | 2022 |